Jonathan Galeotti

654 total citations
23 papers, 477 citations indexed

About

Jonathan Galeotti is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jonathan Galeotti has authored 23 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Jonathan Galeotti's work include Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Jonathan Galeotti is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Jonathan Galeotti collaborates with scholars based in United States, Malawi and Italy. Jonathan Galeotti's co-authors include Junichi Sadoshima, Peiyong Zhai, Sebastiano Sciarretta, Massimo Volpe, Xianzhong Yu, Eric Holle, Thomas E. Wagner, J. Pablo Marquez, Shumin Gao and Chull Hong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Circulation Research.

In The Last Decade

Jonathan Galeotti

21 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Galeotti United States 7 290 139 112 76 52 23 477
Kristen M. Kokkonen-Simon United States 8 276 1.0× 187 1.3× 53 0.5× 51 0.7× 42 0.8× 8 470
Anya Joyo United States 10 457 1.6× 114 0.8× 82 0.7× 61 0.8× 93 1.8× 10 572
Fujun Shi China 9 239 0.8× 94 0.7× 44 0.4× 62 0.8× 57 1.1× 20 463
Gerhild Euler Germany 16 440 1.5× 298 2.1× 73 0.7× 37 0.5× 65 1.3× 33 787
Florence Tortosa France 12 397 1.4× 332 2.4× 70 0.6× 68 0.9× 114 2.2× 13 763
Anna Maria Lucchese United States 11 416 1.4× 161 1.2× 32 0.3× 48 0.6× 73 1.4× 21 577
Zhi‐Ren Zhang China 11 181 0.6× 135 1.0× 37 0.3× 46 0.6× 39 0.8× 25 381
Lei Jiao China 13 443 1.5× 118 0.8× 43 0.4× 49 0.6× 73 1.4× 33 647
Nakon Aroonsakool United States 11 394 1.4× 145 1.0× 29 0.3× 56 0.7× 78 1.5× 14 652
Kambeez Berenji United States 5 568 2.0× 284 2.0× 63 0.6× 77 1.0× 72 1.4× 7 811

Countries citing papers authored by Jonathan Galeotti

Since Specialization
Citations

This map shows the geographic impact of Jonathan Galeotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Galeotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Galeotti more than expected).

Fields of papers citing papers by Jonathan Galeotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Galeotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Galeotti. The network helps show where Jonathan Galeotti may publish in the future.

Co-authorship network of co-authors of Jonathan Galeotti

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Galeotti. A scholar is included among the top collaborators of Jonathan Galeotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Galeotti. Jonathan Galeotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Alexander M., Edwards Kasonkanji, Tamiwe Tomoka, et al.. (2024). HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T‐cell associations in diffuse large B‐cell lymphoma. British Journal of Haematology. 205(1). 194–206. 1 indexed citations
2.
Beck, Samantha, Edwards Kasonkanji, Tamiwe Tomoka, et al.. (2024). Immunogenomic Profiles of EBV-Associated Classic Hodgkin Lymphoma in an HIV-Inclusive Cohort. Blood. 144(Supplement 1). 4344–4344. 1 indexed citations
3.
Xu, Alexander M., Edwards Kasonkanji, Tamiwe Tomoka, et al.. (2024). HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma. JCI Insight. 9(13). 4 indexed citations
4.
Johnson, Steven M., James Haberberger, Jonathan Galeotti, et al.. (2023). Comprehensive genomic profiling reveals molecular subsets of ASXL1 -mutated myeloid neoplasms. Leukemia & lymphoma. 65(2). 209–218. 1 indexed citations
5.
Jensen, Christopher E., Nathan D. Montgomery, Jonathan Galeotti, Matthew C. Foster, & Joshua F. Zeidner. (2022). Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 26(24). 6079–6082. 2 indexed citations
6.
Karachaliou, Georgia Sofia, Rached Alkallas, Nirali M. Patel, et al.. (2022). The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma. BMC Cancer. 22(1). 38–38. 5 indexed citations
7.
Johnson, Steven M., Lori Ramkissoon, James Haberberger, et al.. (2021). Comprehensive Genomic Characterization of ASXL1 C.1934dupG (p.G646fs*12) Versus Other ASXL1 mutations in Myeloid Neoplasia. Blood. 138(Supplement 1). 3466–3466.
8.
Richardson, Daniel R., Dominic T. Moore, Steven M. Johnson, et al.. (2021). Genomic characteristics and prognostic significance of co‐mutatedASXL1/SRSF2acute myeloid leukemia. American Journal of Hematology. 96(4). 462–470. 13 indexed citations
9.
Malpica, Luis, Jonathan Galeotti, Xianming Tan, et al.. (2020). A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas. Leukemia & lymphoma. 61(6). 1508–1511. 3 indexed citations
10.
Eulitt, Patrick, et al.. (2019). Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis. SHILAP Revista de lepidopterología. 7(11). 2274–2276. 1 indexed citations
11.
Richardson, Daniel R., Anastasia Ivanova, Steven M. Johnson, et al.. (2019). ASXL1/SRSF2 Co-Mutated Acute Myeloid Leukemia (AML): A Rare but Distinct Subpopulation with Dismal Outcomes. Blood. 134(Supplement_1). 2598–2598. 1 indexed citations
12.
Galeotti, Jonathan & Catherine C. Coombs. (2018). Enasidenib‐induced eosinophilic differentiation in a patient with acute myeloid leukaemia with IDH2 and U2AF1 mutations. British Journal of Haematology. 184(4). 496–496. 4 indexed citations
13.
Leung, Kenneth, Brian Ezekian, Jonathan Galeotti, Diana M. Cardona, & Dan G. Blazer. (2017). A giant soft tissue lesion of the male perineum: Unusual presentation of a cellular angiofibroma. 4(2). 20–20.
14.
15.
Galeotti, Jonathan, Thomas A. Sporn, Peter Ingram, Momen M. Wahidi, & Victor L. Roggli. (2016). Endogenous pneumoconiosis: Analytical scanning electron microscopic analysis of a case. Ultrastructural Pathology. 40(3). 159–162. 3 indexed citations
16.
Leung, Kenneth, Mathias Worni, Jonathan Galeotti, & Dan G. Blazer. (2016). A Novel Approach: Local Resection for Ampullary GIST—Case Report and Review of Literature. Journal of Gastrointestinal Cancer. 48(4). 376–378. 4 indexed citations
17.
Zhai, Peiyong, Sebastiano Sciarretta, Jonathan Galeotti, Massimo Volpe, & Junichi Sadoshima. (2011). Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion. Circulation Research. 109(5). 502–511. 186 indexed citations
18.
Morisco, Carmine, Chiara Marrone, Jonathan Galeotti, et al.. (2008). Endocytosis machinery is required for β1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovascular Research. 78(1). 36–44. 37 indexed citations
19.
Hirotani, Shinichi, Peiyong Zhai, Hideharu Tomita, et al.. (2007). Inhibition of Glycogen Synthase Kinase 3β During Heart Failure Is Protective. Circulation Research. 101(11). 1164–1174. 97 indexed citations
20.
Zhai, Peiyong, Jonathan Galeotti, Eric Holle, et al.. (2006). An Angiotensin II Type 1 Receptor Mutant Lacking Epidermal Growth Factor Receptor Transactivation Does Not Induce Angiotensin II–Mediated Cardiac Hypertrophy. Circulation Research. 99(5). 528–536. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen M. Kokkonen-Simon Breakdown of academic impact, for papers by Anya Joyo Breakdown of academic impact, for papers by Fujun Shi Breakdown of academic impact, for papers by Gerhild Euler Breakdown of academic impact, for papers by Florence Tortosa Breakdown of academic impact, for papers by Anna Maria Lucchese Breakdown of academic impact, for papers by Zhi‐Ren Zhang Breakdown of academic impact, for papers by Lei Jiao Breakdown of academic impact, for papers by Nakon Aroonsakool Breakdown of academic impact, for papers by Kambeez Berenji
Rankless by CCL
2026